LSX World Congress Plenary Panel – Biotech in 2022: Another wave or low tide?

McKinsey’s Alexandra Zemp and Rachel Moss presented intriguing data and provided timely insights on where they see the markets, currently in turmoil, may go in 2022. The McKinsey partners opened with frightening stats that the biotech public markets have declined 36% since 1 Sept 2021 to May 2022. The IPO window has narrowed significantly, with […]

Riding the Crest of a Digital Wave Transforming Healthcare

At BIO-Europe Spring 2022, Javier Nunez Vicandi of Heal Capital hosted a wide-ranging panel discussion on the timely topic of ‘How Digital Health Technologies Can Support Systemic Change in Healthcare’. The panellists were David Braun from Merck Healthcare, Ed Cox from EVERSANA, Nino da Silva from BC Platforms, and Valerie Kirchberger from Heartbeat Medical. The panel […]

Powering up your BIO-Europe Spring® Partnering

Ready… steady… Go! It’s almost time for another BIO-Europe Spring®, delivered digitally. This is Europe’s premier springtime partnering conference for the biotechnology industry. We have all had a lot of experience doing events digitally now, and we wanted to share some tips on how to power up your BIO-Europe Spring digital partnering experience. View blog post

Staying human in a digital world

Do you remember your first digital conference? Logging on, learning how to navigate the various platforms, and talking business over a webcam. Back then you may have thought this was just a temporary fix and that by now we would be back to enjoying face to face meetings, complementary finger foods, and exploring beautiful cities. […]

Let the Northern Lights Illuminate your BIO-Europe® Partnering

Making a plan for BIO-Europe® Digital in October? This time around we were almost going to be in Stockholm, one of the glittering capitals in the Nordics. But the world doesn’t seem quite ready to kick off its comfy Zoom slippers and try on some new work shoes to walk the walk, as well as talk the talk, for […]

Mobilizing a Bio-Revolution

At the BIO-Europe Spring Opening Plenary “In the thick of it: Navigating beyond vaccine discovery”, Informa Pharma Intelligence’s  Eleanor Malone hosted a discussion with three leading authorities in biotech: Bayer’s Marianne De Backer, Pfizer’s Monika Vnuk, and Medicxi’s Francesco De Rubertis. View blog post

The Key to Playing Harmoniously at BIO-Europe Spring® Digital 2021

Can it really be almost a whole year since BIO-Europe Spring® 2020 went digital? In Groundhog Day, Bill Murray had become a concert pianist by this point in the film, having relived the same day several hundred times over, but wisely spending a little time each day to practice the piano, so he could successfully […]

“Sorry, I was on mute”: Tips for perfect life science partnering during upcoming digital events

The world has changed for us all due to COVID-19, and it can feel like we’ve jumped five years into the future in terms of online interactions using video-conference platforms to get things done. Companies need to adapt to survive and thrive in the new way of interacting with others, so global connections are more important than ever. This […]

Why eating seven M&Ms daily is essential for digital communications success at BIO-Europe Spring®

In light of the restaging of BIO-Europe Spring® 2020, the most important springtime life science partnering conference in Europe, from a three-day onsite event to a five-day fully digital conference, we thought you’d enjoy some pointers on optimum digital engagement. When President Obama was still in office, The New York Times ran a fascinating piece about how he managed his precious hours alone. […]

How sea turtles are essential to success in China

BIO-Europe® 2019’s panel on “The China Market” covered a lot of territory, which is appropriate for a country where sales of pharmaceutical products have doubled since 2013 to over $137bn in 2018, with 2030 predicted to be the year when sales reach 50% of the US market. Hosted by Ruediger Herrmann, partner at McDermott Will & Emery, the panel discussed the market, clinical trials, sophisticated business […]